Safety and Tolerability of Exenatide Once Weekly in Patients With Type 2 Diabetes: An Integrated Analysis of 4328 Patients

被引：0
|
作者：
Macconell, Leigh
Gurney, Kate
Malloy, Jaret
Zhang, H.
Zhou, Ming
Chen, Steve
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2372-PO
引用
收藏
页码：A598 / A598
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients
    MacConell, Leigh
    Gurney, Kate
    Malloy, Jaret
    Zhou, Ming
    Kolterman, Orville
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2015, 8 : 241 - 253
  • [2] Efficacy, Safety, and Tolerability of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus: An Integrated Analysis of the DURATION Trials
    Grimm, Michael
    Han, Jenny
    Weaver, Carole
    Griffin, Pete
    Schulteis, Christine T.
    Dong, Haiying
    Malloy, Jaret
    POSTGRADUATE MEDICINE, 2013, 125 (03) : 47 - 57
  • [3] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients with Type 2 Diabetes
    Iwamoto, Kazuya
    Nasu, Risa
    Yamamura, Ayuko
    Kothare, Prajakti A.
    Mace, Kenneth
    Wolka, Anne M.
    Linnebjerg, Helle
    ENDOCRINE JOURNAL, 2009, 56 (08) : 951 - 962
  • [4] The efficacy and safety of exenatide once weekly in patients with type 2 diabetes
    Heimburger, Sebastian M.
    Bronden, Andreas
    Johansen, Nicklas J.
    Dejgaard, Thomas F.
    Vilsboll, Tina
    Knop, Filip K.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (05) : 501 - 510
  • [5] Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients with Type 2 Diabetes
    Iwamoto, Kazuya
    Nasu, Risa
    Yamamura, Ayuko
    Kothare, Prajakti A.
    Wolka, Anne M.
    Linnebjerg, Helle
    DIABETES, 2009, 58 : A163 - A163
  • [6] Safety of Exenatide Once Weekly in Patients with Type 2 Diabetes Treated with a Thiazolidinedione
    Norwood, Paul
    Pintilei, Ella
    Pop, Lavinia
    Liutkus, Joanne
    Choi, Suktae
    Giaconia, Joseph
    Trautman, Michael
    DIABETES, 2010, 59 : A195 - A195
  • [7] Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes
    Wysham, Carol H.
    Rosenstock, Julio
    Vetter, Marion L.
    Dong, Fang
    Ohman, Peter
    Iqbal, Nayyar
    DIABETES OBESITY & METABOLISM, 2018, 20 (01): : 165 - 172
  • [8] Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis
    Sheu, Wayne H. -H.
    Brunell, Steven C.
    Blase, Erich
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 114 : 160 - 172
  • [9] A Review of the Long-Term Efficacy, Tolerability, and Safety of Exenatide Once Weekly for Type 2 Diabetes
    Stefano Genovese
    Edoardo Mannucci
    Antonio Ceriello
    Advances in Therapy, 2017, 34 : 1791 - 1814
  • [10] Pharmacokinetics, safety, and tolerability of single- and multiple-dose exenatide once weekly in Chinese patients with type 2 diabetes mellitus
    Cui, Yi Min
    Guo, Xiao Hui
    Zhang, Dong Mei
    Tham, Lai San
    Tang, Cheng Cai
    Mace, Kenneth
    Linnebjerg, Helle
    JOURNAL OF DIABETES, 2013, 5 (02) : 127 - 135
12345